Genetic determinants of cardiometabolic risk: A proposed model for phenotype association and interaction

Journal of Clinical Lipidology

Volumn 7, Issue 1, 2013, Pages 65-81

  Blackett, Piers R ^a   Sanghera, Dharambir K ^a  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

Author keywords

Coronary artery disease; Environment; Genes; Metabolic syndrome; Type 2 diabetes

Indexed keywords

11B HYDROXYSTEROID DEHYDROGENASE 1; 5 AMINO 4 IMIDAZOLECARBOXAMIDE RIBOSIDE; ADENOSINE MONOPHOSPHATE ACTIVATED KINASE; INSULIN; OXIDOREDUCTASE; PHOSPHOENOLPYRUVATE CARBOXYKINASE (GTP); PHOSPHOTRANSFERASE; UNCLASSIFIED DRUG;

ADIPOCYTE; AGE; ARTERY ENDOTHELIUM; ARTERY WALL; BRAIN; CARDIOMETABOLIC RISK; CIRCADIAN RHYTHM; DISEASE COURSE; DRUG TARGETING; DYSLIPIDEMIA; EARLY DIAGNOSIS; ENVIRONMENTAL FACTOR; GENE EXPRESSION; GENETIC RISK; GENETIC TRAIT; GENOTYPE; HERITABILITY; HUMAN; HYPERTENSION; HYPOTHALAMUS; INSULIN RELEASE; INSULIN RESISTANCE; KIDNEY; LIPID STORAGE; LIVER; METABOLIC SYNDROME X; METABOLISM; MUSCLE CELL; NON INSULIN DEPENDENT DIABETES MELLITUS; NONALCOHOLIC FATTY LIVER DISEASE ACTIVITY SCORE; OBESITY; PANCREAS ISLET BETA CELL; PHENOTYPE; PLEIOTROPY; PREDICTION; PRIORITY JOURNAL; REVIEW; TREATMENT RESPONSE;

CHOLESTEROL ESTER TRANSFER PROTEINS; DYSLIPIDEMIAS; FATTY LIVER; GENOME-WIDE ASSOCIATION STUDY; HUMANS; HYPERTENSION; HYPOTHALAMIC DISEASES; INSULIN-SECRETING CELLS; LIPOPROTEINS; METABOLIC NETWORKS AND PATHWAYS; MODELS, BIOLOGICAL; PHENOTYPE; PROTEINS;

AVES;

EID: 84872900275     PISSN: 19332874     EISSN: 18764789     Source Type: Journal    
DOI: 10.1016/j.jacl.2012.04.079     Document Type: Review

References (171)

1. S. Mottillo, K.B. Filion, and J. Genest The metabolic syndrome and cardiovascular risk: a systematic review and meta-analysis J Am Coll Cardiol 56 2010 1113 1132
2. J.A. Morrison, E.S. Ford, and J. Steinberger The pediatric metabolic syndrome Minerva Med 99 2008 269 287
3. Y.Z. Wang, Y.N. Huang, K.Y. Sun, J.H. Qi, and L. Xiang Leptin gene transfer regulates fibromuscular development and lipid deposition in muscles via SIRT1, FOXO3a and PGC-1alpha in mice in vivo Int J Mol Med 28 2011 617 623
4. E.S. Ford, C. Li, and N. Sattar Metabolic syndrome and incident diabetes: current state of the evidence Diabetes Care 31 2008 1898 1904
5. G.M. Reaven The metabolic syndrome: time to get off the merry-go-round? J Int Med 269 2011 127 136
6. M.P. Stern, K. Williams, C. Gonzalez-Villalpando, K.J. Hunt, and S.M. Haffner Does the metabolic syndrome improve identification of individuals at risk of type 2 diabetes and/or cardiovascular disease? Diabetes Care 27 2004 2676 2681
7. R. Kahn, J. Buse, E. Ferrannini, and M. Stern The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes Diabetes Care 28 2005 2289 2304
8. E.J. Boyko, R.A. Doheny, M.J. McNeely, S.E. Kahn, D.L. Leonetti, and W.Y. Fujimoto Latent class analysis of the metabolic syndrome Diabetes Res Clin Pract 89 2010 88 93
9. I. Lemieux, A. Pascot, and C. Couillard Hypertriglyceridemic waist: a marker of the atherogenic metabolic triad (hyperinsulinemia; hyperapolipoprotein B; small, dense LDL) in men? Circulation 102 2000 179 184
10. I. Lemieux, P. Poirier, and J. Bergeron Hypertriglyceridemic waist: a useful screening phenotype in preventive cardiology? Can J Cardiol 23 Suppl B 2007 23B 31B
11. K.M. Utzschneider, A. Van de Lagemaat, and M.V. Faulenbach Insulin resistance is the best predictor of the metabolic syndrome in subjects with a first-degree relative with type 2 diabetes Obesity 18 2010 1781 1787
12. J.B. Meigs, M.K. Rutter, and L.M. Sullivan Impact of insulin resistance on risk of type 2 diabetes and cardiovascular disease in people with metabolic syndrome Diabetes Care 30 2007 1219 1225
13. J.V. Neel The "thrifty genotype" in 1998 Nutr Rev 57 1999 S2 S9
14. V.T. Samuel, and G.I. Shulman Mechanisms for insulin resistance: common threads and missing links Cell 148 2012 852 871
15. R. Rabol, K.F. Petersen, S. Dufour, C. Flannery, and G.I. Shulman Reversal of muscle insulin resistance with exercise reduces postprandial hepatic de novo lipogenesis in insulin resistant individuals Proc Natl Acad Sci U S A 108 2011 13705 13709
16. W.S. Garver Gene-diet interactions in childhood obesity Curr Genomics 12 2011 180 189
17. H.M. Farin, F. Abbasi, and G.M. Reaven Body mass index and waist circumference both contribute to differences in insulin-mediated glucose disposal in nondiabetic adults Am J Clin Nutr 83 2006 47 51
18. I.S. Farooqi, and S. O'Rahilly Genetic factors in human obesity Obes Rev 8 Suppl 1 2007 37 40
19. A.J. Stunkard, J.R. Harris, N.L. Pedersen, and G.E. McClearn The body-mass index of twins who have been reared apart N Engl J Med 322 1990 1483 1487
20. I.S. Farooqi, and S. O'Rahilly New advances in the genetics of early onset obesity Int J Obes (Lond) 29 2005 1149 1152
21. I.S. Farooqi, J.M. Keogh, G.S. Yeo, E.J. Lank, T. Cheetham, and S. O'Rahilly Clinical spectrum of obesity and mutations in the melanocortin 4 receptor gene N Engl J Med 348 2003 1085 1095
22. C.E. Martinelli, J.M. Keogh, and J.R. Greenfield Obesity due to melanocortin 4 receptor (MC4R) deficiency is associated with increased linear growth and final height, fasting hyperinsulinemia, and incompletely suppressed growth hormone secretion J Clin Endocrinol Metab 96 2011 E181 E188
23. E.K. Speliotes, C.J. Willer, and S.I. Berndt Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index Nat Genet 42 2010 937 948
24. T.M. Frayling, N.J. Timpson, and M.N. Weedon A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity Science 316 2007 889 894
25. D.M. Hallman, V.C. Friedel, and M.A. Eissa The association of variants in the FTO gene with longitudinal body mass index profiles in non-Hispanic white children and adolescents Int J Obes 36 2012 61 68
26. G. Liu, H. Zhu, Y. Dong, R.H. Podolsky, F.A. Treiber, and H. Snieder Influence of common variants in FTO and near INSIG2 and MC4R on growth curves for adiposity in African- and European-American youth Eur J Epidemiol 26 2011 463 473
27. F. Rutters, A.G. Nieuwenhuizen, F. Bouwman, E. Mariman, and M.S. Westerterp-Plantenga Associations between a single nucleotide polymorphism of the FTO Gene (rs9939609) and obesity-related characteristics over time during puberty in a Dutch children cohort J Clin Endocrinol Metab 96 2011 E939 E942
28. J.R. Gonzalez, M. Gonzalez-Carpio, and R. Hernandez-Saez FTO risk haplotype among early onset and severe obesity cases in a population of Western Spain Obesity 20 2012 909 915
29. T. Gerken, C.A. Girard, and Y.C. Tung The obesity-associated FTO gene encodes a 2-oxoglutarate-dependent nucleic acid demethylase Science 318 2007 1469 1472
30. E. Sonestedt, C. Roos, B. Gullberg, U. Ericson, E. Wirfalt, and M. Orho-Melander Fat and carbohydrate intake modify the association between genetic variation in the FTO genotype and obesity Am J Clin Nutr 90 2009 1418 1425
31. S.D. Rees, M. Islam, and M.Z. Hydrie An FTO variant is associated with Type 2 diabetes in South Asian populations after accounting for body mass index and waist circumference Diabetes Med 28 2011 673 680
32. H. Li, T.O. Kilpelainen, and C. Liu Association of genetic variation in FTO with risk of obesity and type 2 diabetes with data from 96,551 East and South Asians Diabetologia 55 2012 981 995
33. Z. Pausova, C. Syme, and M. Abrahamowicz A common variant of the FTO gene is associated with not only increased adiposity but also elevated blood pressure in French Canadians Circ Cardiovasc Genet 2 2009 260 269
34. S.Y. Lim, H.S. Ha, and H.S. Kwon Factors associated with insulin resistance in a middle-aged non-obese rural population: the Chungju Metabolic Disease Cohort (CMC) Study Epidemiol Health 33 2011 e2011009
35. C. Musso, M. Graffigna, and J. Soutelo Cardiometabolic risk factors as apolipoprotein B, triglyceride/HDL-cholesterol ratio and C-reactive protein, in adolescents with and without obesity: cross-sectional study in middle class suburban children Pediatr Diabetes 12 2011 229 234
36. F. Alvarez Caro, J.J. Diaz Martin, I. Riano Galan, D. Perez Solis, R. Venta Obaya, and S. Malaga Guerrero [Classic and emergent cardiovascular risk factors in schoolchildren in Asturias] Anal Pediatr 74 2011 388 395
37. S.M. Hunter, R.R. Frerichs, L.S. Webber, and G.S. Berenson Social status and cardiovascular disease risk factor variables in children: the Bogalusa Heart Study J Chronic Dis 32 1979 441 449
38. M. Chen, J.L. Breslow, W. Li, and T. Leff Transcriptional regulation of the apoC-III gene by insulin in diabetic mice: correlation with changes in plasma triglyceride levels J Lipid Res 35 1994 1918 1924
39. W.W. Li, M.M. Dammerman, J.D. Smith, S. Metzger, J.L. Breslow, and T. Leff Common genetic variation in the promoter of the human apo CIII gene abolishes regulation by insulin and may contribute to hypertriglyceridemia J Clin Invest 96 1995 2601 2605
40. J. Dallongeville, A. Meirhaeghe, D. Cottel, J.C. Fruchart, P. Amouyel, and N. Helbecque Polymorphisms in the insulin response element of APOC-III gene promoter influence the correlation between insulin and triglycerides or triglyceride-rich lipoproteins in humans Int J Obes Relat Metab Disord 25 2001 1012 1017
41. S. Kathiresan, O. Melander, and C. Guiducci Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans Nat Genet 40 2008 189 197
42. H. Snieder, L.J. van Doornen, and D.I. Boomsma Dissecting the genetic architecture of lipids, lipoproteins, and apolipoproteins: lessons from twin studies Arterioscler Thromb Vasc Biol 19 1999 2826 2834
43. S. Qin, K. Kawano, and C. Bruce Phospholipid transfer protein gene knock-out mice have low high density lipoprotein levels, due to hypercatabolism, and accumulate apoA-IV-rich lamellar lipoproteins J Lipid Res 41 2000 269 276
44. T.M. Larsen, S. Toubro, and M.A. van Baak Effect of a 28-d treatment with L-796568, a novel beta(3)-adrenergic receptor agonist, on energy expenditure and body composition in obese men Am J Clin Nutr 76 2002 780 788
45. C. Posadas Romero [Some physiopathologic features of metabolic syndrome] Arch Cardiol Mexico 77 Suppl 4 2007 S4-42-47
46. N.D. Vaziri Dyslipidemia of chronic renal failure: the nature, mechanisms, and potential consequences Am J Physiol 290 2006 F262 F272
47. W. Le Goff, M. Guerin, and M.J. Chapman Pharmacological modulation of cholesteryl ester transfer protein, a new therapeutic target in atherogenic dyslipidemia Pharmacol Ther 101 2004 17 38
48. N. Sakai, S. Yamashita, and K. Hirano Decreased affinity of low density lipoprotein (LDL) particles for LDL receptors in patients with cholesteryl ester transfer protein deficiency Eur J Clin Invest 25 1995 332 339
49. T. Joy, and R.A. Hegele The end of the road for CETP inhibitors after torcetrapib? Curr Opin Cardiol 24 2009 364 371
50. J.K. Kruit, L.R. Brunham, C.B. Verchere, and M.R. Hayden HDL and LDL cholesterol significantly influence beta-cell function in type 2 diabetes mellitus Curr Opin Lipidol 21 2010 178 185
51. A. Thompson, E. Di Angelantonio, and N. Sarwar Association of cholesteryl ester transfer protein genotypes with CETP mass and activity, lipid levels, and coronary risk JAMA 299 2008 2777 2788
52. M. Nagano, S. Yamashita, and K. Hirano Point mutation (-69 G→A) in the promoter region of cholesteryl ester transfer protein gene in Japanese hyperalphalipoproteinemic subjects Arterioscler Thromb Vasc Biol 21 2001 985 990
53. H. Yilmaz, T. Isbir, B. Agachan, and Z.E. Karaali Effects of cholesterol ester transfer protein Taq1B gene polymorphism on serum lipoprotein levels in Turkish coronary artery disease patients Cell Biochem Function 23 2005 23 28
54. N. Padmaja, M. Ravindra Kumar, S.S. Soya, and C. Adithan Common variants of cholesteryl ester transfer protein gene and their association with lipid parameters in healthy volunteers of Tamilian population Clin Chim Acta 375 2007 140 146
55. J. Rhyne, M.J. Ryan, C. White, T. Chimonas, and M. Miller The two novel CETP mutations Gln87X and Gln165X in a compound heterozygous state are associated with marked hyperalphalipoproteinemia and absence of significant coronary artery disease J Mol Med 84 2006 647 650
56. C.J. Bruce, and R.A. Nishimura Newer advances in the diagnosis and treatment of mitral stenosis Curr Prob Cardiol 23 1998 125 192
57. R.S. Vasan, M.J. Pencina, and S.J. Robins Association of circulating cholesteryl ester transfer protein activity with incidence of cardiovascular disease in the community Circulation 120 2009 2414 2420
58. C.J. Willer, S. Sanna, and A.U. Jackson Newly identified loci that influence lipid concentrations and risk of coronary artery disease Nat Genet 40 2008 161 169
59. R.A. Hegele Plasma lipoproteins: genetic influences and clinical implications Nat Rev Genet 10 2009 109 121
60. D.K. Sanghera, J.S. Bhatti, and G.K. Bhatti The Khatri Sikh Diabetes Study (SDS): study design, methodology, sample collection, and initial results Human Biol 78 2006 43 63
61. A. Schierer, L. Been, S. Ralhan, G. Wander, C. Aston, and D. Sanghera Genetic variation in cholesterol ester transfer protein (CETP), serum CETP activity, and coronary artery disease risk in Asian Indian diabetic cohort Pharmacogenet Genomics 22 2012 95 104
62. G. Targher, C.P. Day, and E. Bonora Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease N Engl J Med 363 2010 1341 1350
63. A. Kotronen, and H. Yki-Jarvinen Fatty liver: a novel component of the metabolic syndrome Arterioscler Thromb Vasc Biol 28 2008 27 38
64. J.D. Brunzell, A. Chait, and E.L. Bierman Pathophysiology of lipoprotein transport Metabolism 27 1978 1109 1127
65. M. Chandalia, S.M. Grundy, B. Adams-Huet, and N. Abate Ethnic differences in the frequency of ENPP1/PC1 121Q genetic variant in the Dallas Heart Study cohort J Diabetes Complications 21 2007 143 148
66. W. Pan, E. Ciociola, and M. Saraf Metabolic consequences of ENPP1 overexpression in adipose tissue Am J Physiol Endocrinol Metab 301 2011 E901 E911
67. M. Chandalia, S.M. Grundy, B. Adams-Huet, and N. Abate Ethnic differences in the frequency of ENPP1/PC1 121Q genetic variant in the Dallas Heart Study cohort J Diabetes Complications 21 2007 143 148
68. J.D. Sparks, and C.E. Sparks Overindulgence and metabolic syndrome: is FoxO1 a missing link? J Clin Invest 118 2008 2012 2015
69. R. Gambino, M. Cassader, G. Pagano, M. Durazzo, and G. Musso Polymorphism in microsomal triglyceride transfer protein: a link between liver disease and atherogenic postprandial lipid profile in NASH? Hepatology 45 2007 1097 1107
70. G. Musso, R. Gambino, and M. Cassader Lipoprotein metabolism mediates the association of MTP polymorphism with beta-cell dysfunction in healthy subjects and in nondiabetic normolipidemic patients with nonalcoholic steatohepatitis J Nutr Biochem 21 2010 834 840
71. K.F. Petersen, S. Dufour, and A. Hariri Apolipoprotein C3 gene variants in nonalcoholic fatty liver disease N Engl J Med 362 2010 1082 1089
72. H.Y. Lee, A.L. Birkenfeld, and F.R. Jornayvaz Apolipoprotein CIII overexpressing mice are predisposed to diet-induced hepatic steatosis and hepatic insulin resistance Hepatology 54 2011 1650 1660
73. M.R. Taskinen, M. Adiels, and J. Westerbacka Dual metabolic defects are required to produce hypertriglyceridemia in obese subjects Arterioscler Thromb Vasc Biol 31 2011 2144 2150
74. W. Qin, M. Sundaram, and Y. Wang Missense mutation in APOC3 within the C-terminal lipid binding domain of human ApoC-III results in impaired assembly and secretion of triacylglycerol-rich very low density lipoproteins: evidence that ApoC-III plays a major role in the formation of lipid precursors within the microsomal lumen J Biol Chem 286 2011 27769 27780
75. C.S. Wang, W.J. McConathy, H.U. Kloer, and P. Alaupovic Modulation of lipoprotein lipase activity by apolipoproteins Effect of apolipoprotein C-III. J Clin Invest 75 1985 384 390
76. A.M. Cali, T.L. Zern, and S.E. Taksali Intrahepatic fat accumulation and alterations in lipoprotein composition in obese adolescents: a perfect proatherogenic state Diabetes Care 30 2007 3093 3098
77. G. Targher, and G. Arcaro Non-alcoholic fatty liver disease and increased risk of cardiovascular disease Atherosclerosis 191 2007 235 240
78. L. Pacifico, V. Cantisani, and P. Ricci Nonalcoholic fatty liver disease and carotid atherosclerosis in children Pediatr Res 63 2008 423 427
79. S. Romeo, J. Kozlitina, and C. Xing Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease Nat Genet 40 2008 1461 1465
80. S. Romeo, F. Sentinelli, and V.M. Cambuli The 148M allele of the PNPLA3 gene is associated with indices of liver damage early in life J Hepatol 53 2010 335 338
81. S. Sookoian, and C.J. Pirola Metabolic syndrome: from the genetics to the pathophysiology Curr Hypertens Rep 13 2011 149 157
82. S. Romeo, F. Sentinelli, and S. Dash Morbid obesity exposes the association between PNPLA3 I148M (rs738409) and indices of hepatic injury in individuals of European descent Int J Obes 34 2010 190 194
83. X. Yuan, D. Waterworth, and J.R. Perry Population-based genome-wide association studies reveal six loci influencing plasma levels of liver enzymes Am J Human Genet 83 2008 520 528
84. S. Sookoian, and C.J. Pirola Meta-analysis of the influence of I148M variant of patatin-like phospholipase domain containing 3 gene (PNPLA3) on the susceptibility and histological severity of nonalcoholic fatty liver disease Hepatology 53 2011 1883 1894
85. M. Pravenec, and E. Petretto Insight into the genetics of hypertension, a core component of the metabolic syndrome Curr Opin Clin Nutr Metab Care 11 2008 393 397
86. J. Basson, J. Simino, and D.C. Rao Between candidate genes and whole genomes: time for alternative approaches in blood pressure genetics Curr Hypertens Rep 14 2012 46 61
87. P.N. Hopkins, and S.C. Hunt Genetics of hypertension Genet Med 5 2003 413 429
88. P. Elliott, and J. Stamler Evidence on salt and blood pressure is consistent and persuasive Int J Epidemiol 31 2002 316 319 discussion 31-32
89. I.J. Brown, J. Stamler, and L. Van Horn Sugar-sweetened beverage, sugar intake of individuals, and their blood pressure: international study of macro/micronutrients and blood pressure Hypertension 57 2011 695 701
90. A. Liu, F. Abbasi, and G.M. Reaven Adiposity indices in the prediction of metabolic abnormalities associated with cardiovascular disease in non-diabetic adults Nutr Metab Cardiovasc Dis 21 2011 553 560
91. M.D. Tobin, M. Tomaszewski, and P.S. Braund Common variants in genes underlying monogenic hypertension and hypotension and blood pressure in the general population Hypertension 51 2008 1658 1664
92. M.D. Tobin, S.M. Raleigh, and S. Newhouse Association of WNK1 gene polymorphisms and haplotypes with ambulatory blood pressure in the general population Circulation 112 2005 3423 3429
93. M.D. Tobin, N.J. Timpson, and L.V. Wain Common variation in the WNK1 gene and blood pressure in childhood: the Avon Longitudinal Study of Parents and Children Hypertension 52 2008 974 979
94. G.B. Ehret, P.B. Munroe, and K.M. Rice Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk Nature 478 2011 103 109
95. J.A. Cutler, P.D. Sorlie, M. Wolz, T. Thom, L.E. Fields, and E.J. Roccella Trends in hypertension prevalence, awareness, treatment, and control rates in United States adults between 1988-1994 and 1999-2004 Hypertension 52 2008 818 827
96. E.R. Fox, J.H. Young, and Y. Li Association of genetic variation with systolic and diastolic blood pressure among African Americans: the Candidate Gene Association Resource study Hum Mol Genet 20 2011 2273 2284
97. S. Rutti, J.A. Ehses, and R.A. Sibler Low- and high-density lipoproteins modulate function, apoptosis, and proliferation of primary human and murine pancreatic beta-cells Endocrinology 150 2009 4521 4530
98. J.K. Kruit, P.H. Kremer, and L. Dai Cholesterol efflux via ATP-binding cassette transporter A1 (ABCA1) and cholesterol uptake via the LDL receptor influences cholesterol-induced impairment of beta cell function in mice Diabetologia 53 2010 1110 1119
99. M. Hao, and J.S. Bogan Cholesterol regulates glucose-stimulated insulin secretion through phosphatidylinositol 4,5-bisphosphate J. Biol Chem 284 2009 29489 29498
100. S.A. Schafer, F. Machicao, A. Fritsche, H.U. Haring, and K. Kantartzis New type 2 diabetes risk genes provide new insights in insulin secretion mechanisms Diabetes Res Clin Pract 93 Suppl 1 2011 S9 S24
101. N.M. De Silva, and T.M. Frayling Novel biological insights emerging from genetic studies of type 2 diabetes and related metabolic traits Curr Opin Lipidol 21 2010 44 50
102. Takeuchi F, Katsuya T, Chakrewarthy S, et al. Common variants at the GCK, GCKR, G6PC2-ABCB11 and MTNR1B loci are associated with fasting glucose in two Asian populations. Diabetologia.53:299-308.
103. E. Reiling, E. van 't Riet, and M.J. Groenewoud Combined effects of single-nucleotide polymorphisms in GCK, GCKR, G6PC2 and MTNR1B on fasting plasma glucose and type 2 diabetes risk Diabetologia 52 2009 1866 1870
104. W.M. Chen, M.R. Erdos, and A.U. Jackson Variations in the G6PC2/ABCB11 genomic region are associated with fasting glucose levels J Clin Invest 118 2008 2620 2628
105. D.K. Sanghera, S.K. Nath, and L. Ortega TCF7L2 polymorphisms are associated with type 2 diabetes in Khatri Sikhs from North India: genetic variation affects lipid levels Ann Hum Genet 72 2008 499 509
106. L.F. Been, S. Ralhan, and G.S. Wander Variants in KCNQ1 increase type II diabetes susceptibility in South Asians: a study of 3,310 subjects from India and the US BMC Med Genet 12 2011 18
107. D.K. Sanghera, L. Ortega, and S. Han Impact of nine common type 2 diabetes risk polymorphisms in Asian Indian Sikhs: PPARG2 (Pro12Ala), IGF2BP2, TCF7L2 and FTO variants confer a significant risk BMC Med Genet 9 2008 59
108. D.K. Sanghera, L.F. Been, and S. Ralhan Genome-wide linkage scan to identify Loci associated with type 2 diabetes and blood lipid phenotypes in the Sikh diabetes study PLoS One 6 2011 e21188
109. A.D. Lampidonis, E. Rogdakis, G.E. Voutsinas, and D.J. Stravopodis The resurgence of Hormone-Sensitive Lipase (HSL) in mammalian lipolysis Gene 477 2011 1 11
110. J. Juhola, C.G. Magnussen, and J.S. Viikari Tracking of serum lipid levels, blood pressure, and body mass index from childhood to adulthood: the Cardiovascular Risk in Young Finns Study J Pediatr 159 2011 584 590
111. M. Juonala, C.G. Magnussen, and A. Venn Influence of age on associations between childhood risk factors and carotid intima-media thickness in adulthood: the Cardiovascular Risk in Young Finns Study, the Childhood Determinants of Adult Health Study, the Bogalusa Heart Study, and the Muscatine Study for the International Childhood Cardiovascular Cohort (i3C) Consortium Circulation 122 2010 2514 2520
112. C.N. Hales, and D.J. Barker Type 2 (non-insulin-dependent) diabetes mellitus: the thrifty phenotype hypothesis Diabetologia 35 1992 595 601
113. K.L. Tamashiro, and T.H. Moran Perinatal environment and its influences on metabolic programming of offspring Physiol Behav 100 2010 560 566
114. H. Ainge, C. Thompson, S.E. Ozanne, and K.B. Rooney A systematic review on animal models of maternal high fat feeding and offspring glycaemic control Int J Obes (Lond) 35 2011 325 335
115. S. Sebert, D. Sharkey, H. Budge, and M.E. Symonds The early programming of metabolic health: is epigenetic setting the missing link? Am J Clin Nutr 94 2011 1953S 1958S
116. J.C. Florez Genetic susceptibility to type 2 diabetes and implications for therapy J Diabetes Sci Technol 3 2009 690 696
117. A. Doria, M.E. Patti, and C.R. Kahn The emerging genetic architecture of type 2 diabetes Cell Metab 8 2008 186 200
118. K.S. Small, A.K. Hedman, and E. Grundberg Identification of an imprinted master trans regulator at the KLF14 locus related to multiple metabolic phenotypes Nat Genet 43 2011 561 564
119. K.L. Monda, K.E. North, S.C. Hunt, D.C. Rao, M.A. Province, and A.T. Kraja The genetics of obesity and the metabolic syndrome Endocr Metab Immune Disord Drug Targets 10 2010 86 108
120. E. Maury, K.M. Ramsey, and J. Bass Circadian rhythms and metabolic syndrome: from experimental genetics to human disease Circ Res 106 2010 447 462
121. G.M. Reaven Banting lecture 1988. Role of insulin resistance in human disease Diabetes 37 1988 1595 1607
122. A.J. Hanley, A.J. Karter, and A. Festa Factor analysis of metabolic syndrome using directly measured insulin sensitivity: the Insulin Resistance Atherosclerosis Study Diabetes 51 2002 2642 2647
123. S.M. Haffner, R. D'Agostino Jr., and A. Festa Low insulin sensitivity (S(i) = 0) in diabetic and nondiabetic subjects in the insulin resistance atherosclerosis study: is it associated with components of the metabolic syndrome and nontraditional risk factors? Diabetes Care 26 2003 2796 2803
124. M.R. Salazar, H.A. Carbajal, and W.G. Espeche Relationships among insulin resistance, obesity, diagnosis of the metabolic syndrome and cardio-metabolic risk Diabetes Vasc Dis Res 8 2011 109 116
125. K.L. Cheal, F. Abbasi, C. Lamendola, T. McLaughlin, G.M. Reaven, and E.S. Ford Relationship to insulin resistance of the adult treatment panel III diagnostic criteria for identification of the metabolic syndrome Diabetes 53 2004 1195 1200
126. E.S. Ford, M.B. Schulze, T. Pischon, M.M. Bergmann, H.G. Joost, and H. Boeing Metabolic syndrome and risk of incident diabetes: findings from the European Prospective Investigation into Cancer and Nutrition-Potsdam Study Cardiovasc Diabetol 7 2008 35
127. J.C. Bruning, J. Winnay, S. Bonner-Weir, S.I. Taylor, D. Accili, and C.R. Kahn Development of a novel polygenic model of NIDDM in mice heterozygous for IR and IRS-1 null alleles Cell 88 1997 561 572
128. K.D. Sinclair, C. Allegrucci, and R. Singh DNA methylation, insulin resistance, and blood pressure in offspring determined by maternal periconceptional B vitamin and methionine status Proc Natl Acad Sci U S A 104 2007 19351 19356
129. C. Gemma, S. Sookoian, and G. Dieuzeide Methylation of TFAM gene promoter in peripheral white blood cells is associated with insulin resistance in adolescents Mol Genet Metab 100 2010 83 87
130. S. Sookoian, M.S. Rosselli, and C. Gemma Epigenetic regulation of insulin resistance in nonalcoholic fatty liver disease: impact of liver methylation of the peroxisome proliferator-activated receptor gamma coactivator 1alpha promoter Hepatology 52 2010 1992 2000
131. V.A. Lira, C.R. Benton, Z. Yan, and A. Bonen PGC-1alpha regulation by exercise training and its influences on muscle function and insulin sensitivity Am J Physiol Endocrinol Metab 299 2010 E145 E161
132. M. Wamil, and J.R. Seckl Inhibition of 11beta-hydroxysteroid dehydrogenase type 1 as a promising therapeutic target Drug Discov Today 12 2007 504 520
133. H. Masuzaki, J. Paterson, and H. Shinyama A transgenic model of visceral obesity and the metabolic syndrome Science 294 2001 2166 2170
134. N.M. Morton, M.C. Holmes, and C. Fievet Improved lipid and lipoprotein profile, hepatic insulin sensitivity, and glucose tolerance in 11beta-hydroxysteroid dehydrogenase type 1 null mice J Biol Chem 276 2001 41293 41300
135. R.S. Lindsay, D.J. Wake, and S. Nair Subcutaneous adipose 11 beta-hydroxysteroid dehydrogenase type 1 activity and messenger ribonucleic acid levels are associated with adiposity and insulinemia in Pima Indians and Caucasians J Clin Endocrinol Metab 88 2003 2738 2744
136. Y. Feng, S.L. Huang, and W. Dou Emodin, a natural product, selectively inhibits 11beta-hydroxysteroid dehydrogenase type 1 and ameliorates metabolic disorder in diet-induced obese mice Br J Pharmacol 161 2010 113 126
137. K. Kannisto, K.H. Pietilainen, and E. Ehrenborg Overexpression of 11beta-hydroxysteroid dehydrogenase-1 in adipose tissue is associated with acquired obesity and features of insulin resistance: studies in young adult monozygotic twins J Clin Endocrinol Metab 89 2004 4414 4421
138. J. Robitaille, C. Brouillette, A. Houde, J.P. Despres, A. Tchernof, and M.C. Vohl Molecular screening of the 11beta-HSD1 gene in men characterized by the metabolic syndrome Obes Res 12 2004 1570 1575
139. S. Nair, Y.H. Lee, and R.S. Lindsay 11beta-Hydroxysteroid dehydrogenase Type 1: genetic polymorphisms are associated with Type 2 diabetes in Pima Indians independently of obesity and expression in adipocyte and muscle Diabetologia 47 2004 1088 1095
140. P.W. Franks, W.C. Knowler, and S. Nair Interaction between an 11betaHSD1 gene variant and birth era modifies the risk of hypertension in Pima Indians Hypertension 44 2004 681 688
141. J. Olza, M. Gil-Campos, and R. Leis A gene variant of 11beta-hydroxysteroid dehydrogenase type 1 is associated with obesity in children Int J Obes (Lond) 2012 [Epub ahead of print]
142. D.G. Hardie AMPK: a key regulator of energy balance in the single cell and the whole organism Int J Obes (Lond) 32 Suppl 4 2008 S7 S12
143. B.B. Zhang, G. Zhou, and C. Li AMPK: an emerging drug target for diabetes and the metabolic syndrome Cell Metab 9 2009 407 416
144. T. Shirai, E. Inoue, Y. Ishimi, and J. Yamauchi AICAR response element binding protein (AREBP), a key modulator of hepatic glucose production regulated by AMPK in vivo Biochem Biophys Res Commun 414 2011 287 291
145. K. Zhou, C. Bellenguez, and C.C. Spencer Common variants near ATM are associated with glycemic response to metformin in type 2 diabetes Nat Genet 43 2011 117 120
146. Y. Shu, S.A. Sheardown, and C. Brown Effect of genetic variation in the organic cation transporter 1 (OCT1) on metformin action J Clin Invest 117 2007 1422 1431
147. M.L. Becker, L.E. Visser, R.H. van Schaik, A. Hofman, A.G. Uitterlinden, and B.H. Stricker Genetic variation in the multidrug and toxin extrusion 1 transporter protein influences the glucose-lowering effect of metformin in patients with diabetes: a preliminary study Diabetes 58 2009 745 749
148. M.L. Becker, L.E. Visser, R.H. van Schaik, A. Hofman, A.G. Uitterlinden, and B.H. Stricker Interaction between polymorphisms in the OCT1 and MATE1 transporter and metformin response Pharmacogenet Genom 20 2010 38 44
149. K.A. Jablonski, J.B. McAteer, and P.I. de Bakker Common variants in 40 genes assessed for diabetes incidence and response to metformin and lifestyle intervention in the diabetes prevention program Diabetes 59 2010 2672 2681
150. J.K. Distefano, and R.M. Watanabe Pharmacogenetics of anti-diabetes drugs Pharmaceuticals (Basel) 3 2010 2610 2646
151. J.K. Wolford, K.A. Yeatts, and S.K. Dhanjal Sequence variation in PPARG may underlie differential response to troglitazone Diabetes 54 2005 3319 3325
152. A.L. Gloyn, M.N. Weedon, and K.R. Owen Large-scale association studies of variants in genes encoding the pancreatic beta-cell KATP channel subunits Kir6.2 (KCNJ11) and SUR1 (ABCC8) confirm that the KCNJ11 E23K variant is associated with type 2 diabetes Diabetes 52 2003 568 572
153. S.F. Grant, G. Thorleifsson, and I. Reynisdottir Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes Nat Genet 38 2006 320 323
154. Y. Cai, J. Yi, Y. Ma, and D. Fu Meta-analysis of the effect of HHEX gene polymorphism on the risk of type 2 diabetes Mutagenesis 26 2011 309 314
155. H. Tanaka, T. Yamamoto, and T. Ban Hex stimulates the hepatocyte nuclear factor 1alpha-mediated activation of transcription Arch Biochem Biophys 442 2005 117 124
156. S. Cauchi, S. Del Guerra, and H. Choquet Meta-analysis and functional effects of the SLC30A8 rs13266634 polymorphism on isolated human pancreatic islets Mol Genet Metab 100 2010 77 82
157. A.L. Gloyn, K. Noordam, and M.A. Willemsen Insights into the biochemical and genetic basis of glucokinase activation from naturally occurring hypoglycemia mutations Diabetes 52 2003 2433 2440
158. E.R. Pearson, L.A. Donnelly, and C. Kimber Variation in TCF7L2 influences therapeutic response to sulfonylureas: a GoDARTs study Diabetes 56 2007 2178 2182
159. W.C. Knowler, E. Barrett-Connor, and S.E. Fowler Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin N Engl J Med 346 2002 393 403
160. A. Brautbar, S.S. Virani, J. Belmont, V. Nambi, P.H. Jones, and C.M. Ballantyne LPL gene variants affect apoC-III response to combination therapy of statins and fenofibric acid in a randomized clinical trial of individuals with mixed dyslipidemia J Lipid Res 53 2012 556 560
161. A. Keech, R.J. Simes, and P. Barter Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial Lancet 366 2005 1849 1861
162. P.M. Nilsson ACCORD and risk-factor control in type 2 diabetes N Engl J Med 362 2010 1628 1630
163. H.N. Ginsberg, M.B. Elam, and L.C. Lovato Effects of combination lipid therapy in type 2 diabetes mellitus N Engl J Med 362 2010 1563 1574
164. O. Olivieri, C. Stranieri, and A. Bassi ApoC-III gene polymorphisms and risk of coronary artery disease J Lipid Res 43 2002 1450 1457
165. P. Alaupovic, P. Blackett, W. Wang, and E. Lee Characterization of the metabolic syndrome by apolipoproteins in the Oklahoma Cherokee J Cardiometab Syndr 3 2008 193 199
166. F.M. Sacks, P. Alaupovic, and L.A. Moye VLDL, apolipoproteins B, CIII, and E, and risk of recurrent coronary events in the Cholesterol and Recurrent Events (CARE) trial Circulation 102 2000 1886 1892
167. D.H. Blankenhorn, P. Alaupovic, E. Wickham, H.P. Chin, and S.P. Azen Prediction of angiographic change in native human coronary arteries and aortocoronary bypass grafts. Lipid and nonlipid factors Circulation 81 1990 470 476
168. F.J. Chaves, J.T. Real, and A.B. Garcia-Garcia Genetic diagnosis of familial hypercholesterolemia in a South European outbreed population: influence of low-density lipoprotein (LDL) receptor gene mutations on treatment response to simvastatin in total, LDL, and high-density lipoprotein cholesterol J Clin Endocrinol Metab 86 2001 4926 4932
169. U. Liljedahl, L. Lind, L. Kurland, L. Berglund, T. Kahan, and A.C. Syvanen Single nucleotide polymorphisms in the apolipoprotein B and low density lipoprotein receptor genes affect response to antihypertensive treatment BMC Cardiovasc Disord 4 2004 16
170. T. Joy, and R.A. Hegele Genetics of metabolic syndrome: is there a role for phenomics? Curr Atheroscler Rep 10 2008 201 208
171. R.A. Hegele Phenomics, lipodystrophy, and the metabolic syndrome Trends Cardiovasc Med 14 2004 133 137